Delay in Presentation and Reperfusion Therapy in ST-Elevation Myocardial Infarction

American Journal of Medicine

Volumn 121, Issue 4, 2008, Pages 316-323

  Ting, Henry H ^a   Bradley, Elizabeth H ^b   Wang, Yongfei ^b   Nallamothu, Brahmajee K ^c   Gersh, Bernard J ^a   Roger, Veronique L ^a   Lichtman, Judith H ^b   Curtis, Jeptha P ^b   Krumholz, Harlan M ^b  

^a Mayo Clinic College of Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Fibrinolysis; Myocardial infarction; Quality; Reperfusion

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; ST SEGMENT ELEVATION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; ODDS RATIO; PROBABILITY; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 40949107649     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.11.017     Document Type: Article

References (27)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
2. Newby L.K., Rutsch W.R., Califf R.M., et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy: GUSTO-1 investigators. J Am Coll Cardiol 27 (1996) 1646-1655
3. Goldberg R.J., Mooradd M., Guriwitz J.H., et al. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (NRMI 2). Am J Cardiol 82 (1998) 259-264
4. Zijlstra F., Patel A., Jones M., et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 23 (2002) 550-557
5. Gibson C.M., Murphy S.A., Kirtane A.J., et al. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 980-987
6. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
7. De Luca G., Suryapranata H., Zijlstra F., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003) 991-997
8. De Luca G., Suryapranata H., Ottervanger J.P., and Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
9. Brodie B.R., Stone G.W., Cox D.A., et al. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. Am Heart J 151 (2006) 1231-1238
10. Brodie B.R., Webb J., Cox D.A., et al. Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). Am J Cardiol 99 (2007) 1680-1686
11. McNamara R.L., Wang Y., Herrin J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 47 (2006) 2180-2186
12. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 44 (2004) E1-E211
13. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing door-to-balloon time in acute myocardial infarction. N Engl J Med 355 (2006) 2308-2320
14. Jacobs A.K., Antman E.A., Ellrodt G., et al. Recommendation to develop strategies to increase the number of ST-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation 113 (2006) 2152-2163
15. Rogers W.J., Canto J.G., Lambrew C.T., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2, and 3. J Am Coll Cardiol 36 (2000) 2056-2063
16. Every N.R., Frederick P.D., Robinson M., et al. A comparison of the National Registry of Myocardial Infarction 2 with the Cooperative Cardiovascular Project. J Am Coll Cardiol 33 (1999) 1886-1894
17. Bland J.M., and Altman D.G. The use of transformation when comparing two means. BMJ 312 (1996) 1153
18. Bland J.M., and Altman D.G. Transformations, means, and confidence intervals. BMJ 312 (1996) 1079
19. King G., Tomz M., and Wittenberg J. Making the most of statistical analyses: improving interpretation and presentation. Am J Pol Sci 44 (1998) 341-355
20. Nallamothu B.K., Bates E.R., Herrin J., et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction 3/4 analysis. Circulation 111 (2005) 761-767
21. Magid D.K., Wang Y., Herrin J., et al. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA 294 (2005) 803-812
22. Moser D.K., Kimble L.P., Alberts M.J., et al. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke. Circulation 114 (2006) 168-182
23. Luepker R.V., Raczynski J.M., Osganian S., et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease. JAMA 284 (2000) 60-67
24. Goldberg R.J., Gurwitz J.H., and Gore J.M. Duration of and temporal trends (1994-1997) in prehospital delay in patients with acute myocardial infarction: the Second National Registry of Myocardial Infarction. Arch Intern Med 159 (1999) 2141-2147
25. Goldberg R.J., Yarzebski J., Lessard D., and Gore J.M. Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worchester Heart Attack Study. Arch Intern Med 160 (2000) 3217-3223
26. McGinn A.P., Rosamond W.D., Goff D.C., et al. Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: experience in 4 U.S. communities from 1987-2000. Am Heart J 150 (2005) 392-400
27. Luepker R.V. Delay in acute myocardial infarction: why don't they come to the hospital more quickly and what we can do to reduce delay. Am Heart J 150 (2005) 368-370